From: Virological efficacy and immunological recovery among Ethiopian HIV-1 infected adults and children
Number of patients | |||
---|---|---|---|
Variables | Adults | Children | |
WHO clinical stage | |||
I | 3 | 4 | |
II | 11 | 6 | |
III | 72 | 57 | |
IV | 14 | 33 | |
Anaemia status (%)a | |||
Anaemic | 62 | 67 | |
Non anaemic | 38 | 33 | |
CD4 cell count (cells/mm3)b | |||
<50 | 6 | 0 | |
50-99 | 25 | 5 | |
100-199 | 55 | 14 | |
200-349 | 14 | 33 | |
≥350 | 0 | 48 | |
Total duration on ART (months) | |||
13-24 | 100 | 100 | |
25-36 | 47 | 56 | |
37-48 | 13 | 23 | |
49-60 | 4 | 15 | |
≥61 | 0 | 5 | |
ART regimen | |||
1a: 3TC + d4T + NVP | 39 | 57 | |
1b: 3TC + d4T + EFV | 32 | 5 | |
1c: 3TC + AZT** + NVP | 17 | 35 | |
1d: 3TC + AZT + EFV*** | 12 | 3 |